QURE

uniQure N.V.

QURE·N90064101·US·Common Stock·Healthcare - Biotechnology-13D/G

QURE (uniQure N.V.) is held by 115 institutional investors as of Q2 2026. Largest holders: Avoro Capital Advisors LLC ($309.9M), JPMORGAN CHASE & CO ($230.8M), RTW INVESTMENTS, LP ($181.5M). Net institutional sentiment: Bullish.

115
Holders
(7 Elite)
$2.1B
Total Value
68% (124)
Consensus
84 buying - 40 selling
13F: Insider & Congress: Updated regularly
QURE

Smart Money Verdict

View all
Loading verdict
Held by 115 funds
7 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Jun 22, 2026 · Activists Aug 14, 2026 · Congress none

ActivistRTW Investments, LPRTW Investments, LP5.7%Aug 14, 2026
ActivistGEG1 Execution Services, LLC4.8%Aug 14, 2026
ActivistAberdeen Group plcAberdeen Group plc4.5%Jul 20, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
6.7M(+12.9%)$309.9M2.8%+92.98%
61
Increased
4.9M(+71.5%)$230.8M0.0%+53.48%
46
Increased
3.9M(+52.4%)$181.5M1.6%+106.21%
67
Increased
2.9M(+28.5%)$133.8M0.0%+82.08%
38
Decreased
2.8M(-46.3%)$131.2M0.2%+298.07%
0
Increased
1.9M(+8.3%)$86.5M0.0%+119.36%
32
Increased
1.6M(+153.2%)$74.2M0.0%+62.07%
48
Increased
1.6M(+26.6%)$71.9M0.0%+12.48%
37
Increased
1.5M(+16.8%)$68M0.0%+64.20%
34
Decreased
1.5M(-45.4%)$67.3M0.0%+345.77%
0
Decreased
1.3M(-27.2%)$58.5M0.0%+1.53%
0
Increased
1.1M(+191.3%)$49.1M0.0%+41.82%
47
Increased
925,383(+32.6%)$42.6M0.4%+77.57%
45
Increased
910,338(+125.0%)$41.9M0.0%+61.63%
47
Increased
909,141(+11.3%)$41.9M0.2%+101.74%
39
Increased
860,631(+7.0%)$39.7M0.0%+62.24%
31
Increased
779,779(+12.2%)$35.9M0.0%+289.85%
33
New
627,823$28.9M0.0%+10.62%
40
New
606,212$27.9M0.0%+10.62%
40
Decreased
586,582(-39.2%)$27M0.0%+426.33%
0

Showing 1-20 of 127

1 / 7
QUREQUREuniQure N.V.

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used